CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for NeoGenomics, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

NeoGenomics, Inc.
9490 Neogenomics Way
Phone: (239) 768-0600p:239 768-0600 FORT MYERS, FL  33912  United States Ticker: NEONEO
Business Summary
NeoGenomics, Inc. is a cancer diagnostics company specializing in cancer genetics testing and information services. The Company offers comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with diagnostic and predictive testing to help them diagnose and treat cancer. Its services include clinical cancer testing; interpretation and consultative services; molecular and NGS testing; comprehensive technical and professional services offering; clinical trials and research; validation laboratory services, and oncology data solutions. It operates a network of laboratories for full-service sample processing and analysis services throughout the United States and a full-service sample-processing laboratory in Cambridge, United Kingdom. Its testing services include Cytogenetics (karyotype analysis), Fluorescence In-Situ Hybridization (FISH), Flow cytometry, and others.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202412/31/2024YesYes--Yes

Industries
SIC Code Description
8734 Testing laboratories
8071 Medical laboratories

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board Lynn A.Tetrault 61 8/15/2022 6/12/2015
Chief Executive Officer, Director Christopher M.Smith 61 8/15/2022 8/15/2022
Chief Financial Officer Jeffrey S.Sherman 58 12/7/2022 12/7/2022
9 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Inivata Limited The Portway Building Cambridge United Kingdom
Clarient Diagnostic Services, Inc. 31 Columbia Aliso Viejo CA United States
Clarient, Inc. 31 Columbia Aliso Viejo CA United States
5 additional Subsidiary records available in full report.

Business Names
Business Name
Inivata Limited
NEO
NeoGenomics Bioinformatics, Inc.
9 additional Business Names available in full report.

General Information
Number of Employees: 2,200 (As of 12/31/2024)
Outstanding Shares: 128,461,383 (As of 2/11/2025)
Shareholders: 615
Stock Exchange: NASD
Federal Tax Id: 742897368
Fax Number: (775) 329-0852


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, March 28, 2025